TY - JOUR
T1 - Fructose
T2 - Incomplete Intestinal Absorption in Humans
AU - Ravich, William J.
AU - Bayless, Theodore M.
AU - Thomas, Miriam
PY - 1983/1/1
Y1 - 1983/1/1
N2 - Fructose is an increasingly important commercial sweetener. However, some patients report abdominal symptoms after ingesting fructose-containing foods. The completeness of fructose absorption by the small intestine was assessed by breath hydrogen analysis in 16 healthy volunteers and incomplete absorption was defined as a peak rise in breath hydrogen of 〉20 parts per million. Fructose, 50 g as a 10% solution, was incompletely absorbed in 6 of 16 subjects (37.5%). Incomplete absorption was associated with symptoms of cramps or diarrhea, or both, in 5 of these 6 individuals. Incomplete absorption was both concentration- and dose-related. Three subjects incompletely absorbed 37.5 g of fructose. In comparison, all 15 subjects who were studied after ingestion of sucrose, 50 g as a 10% solution, completely absorbed this sugar load. Incomplete absorption of fructose should be considered as a possible cause of gastrointestinal symptoms.
AB - Fructose is an increasingly important commercial sweetener. However, some patients report abdominal symptoms after ingesting fructose-containing foods. The completeness of fructose absorption by the small intestine was assessed by breath hydrogen analysis in 16 healthy volunteers and incomplete absorption was defined as a peak rise in breath hydrogen of 〉20 parts per million. Fructose, 50 g as a 10% solution, was incompletely absorbed in 6 of 16 subjects (37.5%). Incomplete absorption was associated with symptoms of cramps or diarrhea, or both, in 5 of these 6 individuals. Incomplete absorption was both concentration- and dose-related. Three subjects incompletely absorbed 37.5 g of fructose. In comparison, all 15 subjects who were studied after ingestion of sucrose, 50 g as a 10% solution, completely absorbed this sugar load. Incomplete absorption of fructose should be considered as a possible cause of gastrointestinal symptoms.
UR - http://www.scopus.com/inward/record.url?scp=0020656627&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020656627&partnerID=8YFLogxK
U2 - 10.1016/S0016-5085(83)80162-0
DO - 10.1016/S0016-5085(83)80162-0
M3 - Article
C2 - 6847852
AN - SCOPUS:0020656627
SN - 0016-5085
VL - 84
SP - 26
EP - 29
JO - Gastroenterology
JF - Gastroenterology
IS - 1
ER -